Scholar Rock Holding (SRRK) EBT Margin (2019 - 2022)
Scholar Rock Holding (SRRK) posted quarterly EBT Margin of 27.7% for Q1 2022, up 306990.0% year-over-year from N/an in Q1 2021, and up 96.88% quarter-over-quarter from 887.92% in Q4 2021.
Analysis
Scholar Rock Holding (SRRK) EBT Margin (2019 - 2022) Analysis & Trends
Scholar Rock Holding's EBT Margin history runs 4 years deep, the most recent figure standing at 27.7% for Q1 2022.
- In Q1 2022, EBT Margin rose 306990.0% year-over-year to 27.7%; the TTM figure through Dec 2022 stood at 426.72% (up 141497.0% YoY), while the FY2022 annual figure was 908.76%, up 44197.0% from the prior year.
- EBT Margin for Q1 2022 stood at 27.7%, up from 887.92% in the prior quarter.
- The five-year high for EBT Margin was 27.7% in Q1 2022, with the low at 3097.6% in Q1 2021.
- The 4-year median for EBT Margin is 887.92% (2021), against an average of 1038.03%.
- The sharpest annual moves came in 2021 and 2022: EBT Margin plunged 263333 bps in 2021, then surged 306990 bps in 2022.
- Scholar Rock Holding's EBT Margin stood at 151.33% in 2019, then tumbled by 391 bps to 743.45% in 2020, then decreased by 19 bps to 887.92% in 2021, then jumped by 97 bps to 27.7% in 2022.
- Business Quant data shows SRRK's EBT Margin at 27.7% in Q1 2022, 887.92% in Q4 2021, and 1604.78% in Q3 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.92 Bn | 131.07 Bn | 2.84 Bn | 41.75% |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn | 35.61% |
| 3 | Argenx Se | 63.55 Bn | 58.37 Bn | 1.37 Bn | 35.78% |
| 4 | Moderna | 58.26 Bn | 53.13 Bn | 52.00 Mn | -528.97% |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | - |
| 6 | BeOne Medicines | 39.98 Bn | 34.89 Bn | 1.53 Bn | 18.33% |
| 7 | Alnylam Pharmaceuticals | 35.32 Bn | 32.01 Bn | 992.69 Mn | 13.77% |
| 8 | Royalty Pharma | 28.42 Bn | 27.59 Bn | - | 12.09% |
| 9 | Insmed | 27.41 Bn | 26.25 Bn | 358.27 Mn | -2.67% |
| 10 | Scholar Rock Holding | 7.23 Bn | 7.23 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2022 | -20.89% |
| Dec 31, 2021 | -873.40% |
| Sep 30, 2021 | -678.57% |
| Jun 30, 2021 | -658.82% |
| Mar 31, 2021 | -577.89% |
| Dec 31, 2020 | -759.72% |
| Sep 30, 2020 | -777.68% |
| Jun 30, 2020 | -499.03% |
| Mar 31, 2020 | -351.77% |
| Dec 31, 2019 | -163.04% |
| Sep 30, 2019 | -358.32% |
| Jun 30, 2019 | -265.65% |
| Mar 31, 2019 | -376.79% |